ROTTERDAM, The Netherlands, March 1, 2010 /PRNewswire/ --
- SIMPLE Antibody(TM) Platform Delivers Unprecedented Choice
of Ultra-Potent Functional Antibody Leads Against Challenging Soluble
and Cell Surface Targets.
- ARGX-109, a Fully Human mAb Targeting Autoimmune,
I